Lanthanides Gd and Tm Can Inhibit Carnitine/Acylcarnitine Transporter: Insights from All‐Atoms Simulations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Lanthanides Gd and Tm Can Inhibit Carnitine/Acylcarnitine Transporter: Insights from All‐Atoms Simulations ; day:12 ; month:02 ; year:2025 ; extent:10
ChemBioChem ; (12.02.2025) (gesamt 10)
- Urheber
-
Prejanò, Mario
Tonazzi, Annamaria
Giangregorio, Nicola
Indiveri, Cesare
Marino, Tiziana
- DOI
-
10.1002/cbic.202401018
- URN
-
urn:nbn:de:101:1-2502121330550.841027404675
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Prejanò, Mario
- Tonazzi, Annamaria
- Giangregorio, Nicola
- Indiveri, Cesare
- Marino, Tiziana
Ähnliche Objekte (12)
Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
Identification and characterization of a carnitine transporter in Acinetobacter baumannii
Oligomeric structure of the carnitine transporter CaiT from Escherichia coli
A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features
Carnitine transporter OCTN2 and carnitine uptake in bovine kidney cells is regulated by peroxisome proliferator-activated receptor β/δ
Carnitine transporter OCTN2 and carnitine uptake in bovine kidney cells is regulated by peroxisome proliferator-activated receptor beta/delta
Carnitine today
Structural and Dynamic Assessment of Disease‐Causing Mutations for the Carnitine Transporter OCTN2
Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity
Carnitine and cardiovascular diseases
Carnitine in valproate-induced hyperammonemia
Clinical aspects of human carnitine deficiency
Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
Identification and characterization of a carnitine transporter in Acinetobacter baumannii
Oligomeric structure of the carnitine transporter CaiT from Escherichia coli
A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features
Carnitine transporter OCTN2 and carnitine uptake in bovine kidney cells is regulated by peroxisome proliferator-activated receptor β/δ
Carnitine transporter OCTN2 and carnitine uptake in bovine kidney cells is regulated by peroxisome proliferator-activated receptor beta/delta
Carnitine today
Structural and Dynamic Assessment of Disease‐Causing Mutations for the Carnitine Transporter OCTN2
Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity
Carnitine and cardiovascular diseases
Carnitine in valproate-induced hyperammonemia
Clinical aspects of human carnitine deficiency
Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
Identification and characterization of a carnitine transporter in Acinetobacter baumannii
Oligomeric structure of the carnitine transporter CaiT from Escherichia coli
A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features
Carnitine transporter OCTN2 and carnitine uptake in bovine kidney cells is regulated by peroxisome proliferator-activated receptor β/δ
Carnitine transporter OCTN2 and carnitine uptake in bovine kidney cells is regulated by peroxisome proliferator-activated receptor beta/delta
Carnitine today
Structural and Dynamic Assessment of Disease‐Causing Mutations for the Carnitine Transporter OCTN2
Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity
Carnitine and cardiovascular diseases
Carnitine in valproate-induced hyperammonemia